GTBIF
Green Thumb Industries

6,036
Mkt Cap
$1.36B
Volume
388,142.00
52W High
$9.73
52W Low
$4.63
PE Ratio
31.60
GTBIF Fundamentals
Price
$5.85
Prev Close
$5.29
Open
$5.40
50D MA
$7.46
Beta
0.76
Avg. Volume
389,043.52
EPS (Annual)
$0.3021
P/B
0.74
Rev/Employee
$236,904.38
Loading...
Loading...
News
all
press releases
Cannabis Stocks Drop As Shutdown Deal Tightens Hemp-THC Rules
The U.S. government funding bill to end the shutdown included language tightening rules on hemp-derived THC products.
Stocktwits·11d ago
News Placeholder
More News
News Placeholder
Green Thumb Industries Inc. (GTBIF) Q3 Earnings and Revenues Top Estimates
Green Thumb Industries Inc. (GTBIF) delivered earnings and revenue surprises of +33.33% and +0.24%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·18d ago
News Placeholder
Should You Buy, Hold or Sell VRNO Stock Post Q3 Earnings Release?
Verano's Q3 results show pressure from U.S. price competition and margin compression, but cost cuts and new products signal longer-term optimism.
Zacks·19d ago
News Placeholder
Can TerrAscend Deliver a Solid Q3 on Core Market Strength Ahead?
TSNDF's Q3 results are likely to benefit from Northeast market strength, margin gains, and a streamlined focus following its Michigan exit.
Zacks·21d ago
News Placeholder
AtriCure (ATRC) Reports Q3 Loss, Beats Revenue Estimates
AtriCure (ATRC) delivered earnings and revenue surprises of +90.91% and +2.09%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·26d ago
News Placeholder
Stock Market News for Sep 30, 2025
Wall Street closed higher on Monday, driven by tech and financial stocks.
Zacks·2mo ago
News Placeholder
Here's Why JAZZ Stock Is an Unconventional Cannabis Investment
Jazz Pharma is redefining cannabis investing with Epidiolex, a fast-growing FDA-approved epilepsy drug fueling its growth.
Zacks·2mo ago
News Placeholder
Green Thumb Launches $50M Buyback: Time to Get Bullish on the Stock?
GTBIF launches a $50 million share buyback program, signaling confidence in long-term growth despite market and pricing pressures.
Zacks·2mo ago
News Placeholder
Cannabis Stock CRLBF Gains 25% in a Month: Time to Buy, Sell or Hold?
CRLBF surges 25% this month on reform hopes, but revenue declines, margin pressure and stiff competition cloud its outlook.
Zacks·2mo ago
News Placeholder
Cannabis Stock VRNOF Soars 178% in a Month: Time to Buy, Sell or Hold?
Verano's stock has surged 178% in a month on reform hopes, but pricing pressure and stiff competition test its momentum.
Zacks·3mo ago

Latest GTBIF News

View

Advertisement|Remove ads.

Advertisement|Remove ads.